Hints and tips:
...In late 2020 the Financial Times reported that Talpins’ firm had made a highly prescient call that the results from Pfizer’s phase 3 coronavirus vaccine trials would stun the market by having a higher efficacy...
...Later reports by journalists who were given the documents alleged that the Biden administration had pressed Twitter to silence Covid vaccine doubters, including suspending the accounts of some critics....
...The company has already delivered AI-designed molecules for infectious disease vaccines to a large pharmaceutical company....
...For Shashua of Mobileye, the relevant analogy is vaccines. A life-saving inoculation for the vast majority of the population could still react poorly with a tiny minority of people, he says....
...Two weeks later, the companies announced the vaccine was more than 90 per cent effective, sparking a huge rally in many stocks....
...We asked each chatbot to come up with a new slogan for an imagined gourmet dog desserts company. Here are their attempts....
...Englander’s Millennium Management in 2007 and still primarily manages money on behalf of it, was briefly rumbled in the equity market ructions on November 9 sparked by a breakthrough in the hunt for a Covid-19 vaccine...
...Engineering hope Thanks to the $19bn cash pile amassed after developing a successful Covid vaccine, Germany’s BioNTech is now looking to transform oncology for its next act, the FT reports....
...“But no one was using offshore companies in Antigua during the Crusades.”...
...Derrick Rossi, a prominent stem cell biologist whose research contributed to the messenger RNA Covid-19 vaccines, said he did not “know what she’s talking about”....
...“The accelerated rollout of vaccines globally suggests we are on a strong path to recovering from the economic crisis, but the effectiveness of the vaccines against new strains and the extent to which health...
...“To keep the economy and their operations open, businesses are going to need strong testing infrastructure alongside the vaccine rollout. Covid is going to be with us for the long haul....
...Most of its listed team seem to have moved to another biotech company, Alvea, which is trying to develop DNA-based Covid-19 vaccines. Its ‘come work for us’ link is a mailto — much more sturdy....
...Americans faced another grim wave of the pandemic as the weather cooled with no Covid-19 vaccine in sight....
...Pichai told Google employees that implementation of the vaccine policy “will vary according to local conditions and regulations, and will not apply until vaccines are widely available in your area”....
...Founded in 2014, the California-headquartered start-up has made its name in Africa by supplying hospitals with blood, medicine and vaccines, completing more than 150,000 missions in the past five years....
...The 14-year-old company will merge with 890 Fifth Avenue Partners, a special purpose acquisition company that raised $288m earlier this year. 3....
...Social media companies are facing renewed pressure to clamp down on a small but dedicated group of anti-vaccine campaigners that researchers blame for flooding platforms with misinformation....
...G42 has played a central role in the UAE’s response to coronavirus, partnering with Chinese companies to boost testing capacity and vaccine development....
...companies and received investment from Carlyle in 2018....
...Plus, the FT’s Washington bureau chief James Politi has details on the US’s offer to the rest of the world to tax multinational companies....
...Investors have instead placed big bets on companies generating increasing profits in the near term, including those expected to benefit from the Covid-19 vaccine rollout and reopening of the US economy....
...“There’s no vaccine for climate change but as floods worsen, New York and London will beef up their protective barriers,” he writes. “The destruction of the Amazon is climate’s Delta variant....
...been holding yields down to lower levels than we would see in the absence of historically aggressive market intervention,” said Marty Fridson, chief investment officer of Lehmann Livian Fridson Advisors LLC...
International Edition